| [1] |
Steinberg ZL, Dominguez-Islas CP, Otto CM, et al. Maternal and fetal outcomes of anticoagulation in pregnant women with mechanical heart valves [J]. J Am Coll Cardiol, 2017, 69(22):2681-2691.
|
| [2] |
Lawley CM, Algert CS, Ford JB, et al. Heart valve prostheses in pregnancy: Outcomes for women and their infants [J]．J Am Heart Assoc, 2014, 3(3):1-8.
|
| [3] |
Goland S, Elkayam U. Anticoagulation in pregnancy [J]. Cardiol Clin, 2012，30(3):395-405.
|
| [4] |
Golby AJ, Bush EC, DeRook FA, et al. Failure of high dose heparin to prevent recurrent cardioembolic strokes in a pregnant patient with a mechanical heart valve [J]. Neurology，1992，42(11):2204-2206.
|
| [5] |
Watson WJ, Freeman J, O′Brien C, et al. Embolic stroke in a pregnant patient with a mechanical heart valve on optimal heparin therapy [J]. Am J Perinatol，1996，13(6):371-372.
|
| [6] |
Sbarouni E, Oakley CM. Outcome of pregnancy in women with valve prostheses [J]. Br Heart J，1994, 71(2):196-201.
|
| [7] |
Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin [J]．N Engl J Med，1995，332(20):1330-1335.
|
| [8] |
Maliha G, Morgan J, Vrahas M. Transient osteoporosis of pregnancy [J]. Injury，2012，43(8):1237-1241.
|
| [9] |
Ginsberg JS, Greer I, Hirsh J. Use of antithrombotic agents during pregnancy [J]. Chest, 2001，119(1 Suppl):122s-131s.
|
| [10] |
Oran B, Lee-Parritz A, Ansell J. Low molecular weight heparin for the prophylaxis of thromboembolism in women with prosthetic mechanical heart valves during pregnancy [J]. Thromb Haemost, 2004, 92(4):747-751.
|
| [11] |
McLintock C, McCowan LM, North RA. Maternal complications and pregnancy outcome in women with mechanical prosthetic heart valves treated with enoxaparin [J]. BJOG，2009，116(12):1585-1592.
|
| [12] |
Galambosi P, Hiilesmaa V, Ulander VM, et al. Prolonged low- molecular-weight heparin use during pregnancy and subsequent bone mineral density [J]. Thromb Res，2016，143:122-126.
|
| [13] |
Le Templier G, Rodger MA. Heparin-induced osteoporosis and pregnancy [J]. Curr Opin Pulm Med, 2008, 14(5):403-407.
|
| [14] |
中华医学会妇产科学分会产科学组．妊娠合并心脏病诊治专家共识(2016)[J]．中华妇产科杂志，2016，51(6):401-409.
|
| [15] |
Regitz-Zagrosek V, Blomstrom Lundqvist C, Borghi C, et al. European Society of Gynecology (ESG); Association for European Paediatric Cardiology (AEPC); German Society for Gender Medicine (DGesGM), ESC Committee for Practice Guidelines. ESC guidelines on the management of cardiovascular diseases during pregnancy: the task force on the Management of Cardiovascular Diseases during pregnancy of the European Society of Cardiology (ESC) [J]. Eur Heart J, 2011, 32(24):3147-3197.
|
| [16] |
Nishimura RA, Otto CM, Bonow RO, et al. 2014 AHA/ACC guideline for the Management of Patients with Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines [J]. Circulation，2014，129(23):2440-2492.
|
| [17] |
Bates SM, Greer IA, Middeldorp S, et al. VTE, thrombophilia, an-tithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines [J]. Chest, 2012，141(2 Suppl):e691S-e736S.
|
| [18] |
Arya R. Pregnancy outcomes in women with mechanical prosthetic heart valves [J]．Thrombosis Research, 2019，181(1):S37-S40.
|
| [19] |
Nishimura RA, Warnes CA. Anticoagulation during pregnancy in women with prosthetic valves: evidence, guidelines and unanswered questions [J]. Heart，2015，101(6):430-435.
|